NeuroPace Revenue and Competitors

Location

$247.3M

Total Funding

Estimated Revenue & Valuation

  • NeuroPace's estimated annual revenue is currently $71.5M per year.(i)
  • NeuroPace's estimated revenue per employee is $313,750
  • NeuroPace's total funding is $247.3M.

Employee Data

  • NeuroPace has 228 Employees.(i)
  • NeuroPace grew their employee count by 1% last year.

NeuroPace's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CFO, VP Finance & AdministrationReveal Email/Phone
3
VP SalesReveal Email/Phone
4
VP Product DevelopmentReveal Email/Phone
5
VP, MarketingReveal Email/Phone
6
VP, Manufacturing & Commerical Operations, and ITReveal Email/Phone
7
VP Regulatory AffairsReveal Email/Phone
8
VP, Human ResourcesReveal Email/Phone
9
VP, Human Resources & Corporate ServicesReveal Email/Phone
10
VP, Clinical ResearchReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is NeuroPace?

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. Patients are currently being enrolled in a clinical trial of the company's Responsive Neurostimulator (RNS™) system for treating medically refractory epilepsy.

keywords:Biotechnology

$247.3M

Total Funding

228

Number of Employees

$71.5M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NeuroPace News

2022-04-19 - Global Neural Control Interface Market 2022 Latest ...

NeuroPace Inc; Mindmaze SA; CTRL-Labs (Facebook); BrainCo; Brain Products GmbH; G.TEC; Emotiv Inc; Blackrock Microsystems LLC; InteraXon...

2022-04-17 - NeuroPace, Inc. (NASDAQ:NPCE) Given Average Rating of ...

NeuroPace, Inc operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive...

2022-04-13 - NeuroPace to Report First Quarter 2022 Financial Results on ...

MOUNTAIN VIEW, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$51.1M233-16%$164M
#2
$53M2350%N/A
#3
$38.1M2390%N/A
#4
$29.2M240-4%$115.7M
#5
$71.6M241-5%N/A